Intraoperative optical identification of pituitary adenomas
- 357 Downloads
Introduction The main goals of transsphenoidal pituitary surgery are total removal of pituitary adenomas (PAs) and preservation of normal pituitary functions. Achieving these goals is dependant upon the precise localisation of PAs during surgery, particularly secreting microadenomas. However, some microadenomas are invisible on preoperative imaging and during surgery, leading some surgeons to perform total hypophysectomy in many patients to achieve cure at the expense of panhypopituitrism. We have examined optical detection systems to identify PAs intraoperatively. This paper reports our preliminary findings. Methods A prospective observational study design. Technique Patients were given 20 mg/kg body weight 5-aminolevulinic acid (ALA) mixed in 30 ml of orange juice, orally 3 h before surgery. Surgery was performed in the supine position, under image guidance, through the right nostril using Storz 0 degree endoscope assisted with microsurgery as required. The endoscope was attached to photodiagnostic filters (PD) allowing switching the light from white to blue at the flick of a foot pedal. After the dura of the floor of the sella was incised a laser probe was inserted into the pituitary gland to identify the ALA-induced protoporphyrin IX spectroscopy at 632 nm, using an optical biopsy system (OBS). Once the adenoma was identified by the OBS it was exposed and examined by the PD system to detect fluorescence. The PA was removed and its type was confirmed by histopathology and correlated to the OBS and PD system findings. Patients Thirty consecutive patients were studied: 14 were non-functioning macroadenomas (NFA), 12 were secreting PAs and 4 pituitary cysts. The secreting PAs were GH (2), ACTH (3), prolactin (2) and gonadotrophins (5). Six were microadenomas (3 ACTH, 1 GH, 2 prolactin) and 20 were macroadenomas, of which 12 were invading macroadenomas. Twenty-four of these were examined by the OBS and the PD systems and six were examined by the PD system only. The true positive (sensitivity) of the PD and OBS systems were 80.8% (21/26) and 95.5% (21/22) respectively. The true negative (specificity) of PD and OBS were 75% (3/4) and 100% (2/2) respectively. The false negative rate of PD was 19.2% (5/26) and for OBS was 4.5% (1/22), while the false positive rate for PD was 25% (1/4) and for OBS was 0. Conclusion Intraoperative optical identification of pituitary adenomas is a feasible and reliable way to localize pituitary adenomas during transsphenoidal surgery and it may lead to improved cure rate and preservation of normal pituitary functions.
KeywordsAdenoma Acromegaly Cushing’s disease Localization Photodiagnosis Pituitary
We would like to acknowledge the financial support of Barbara Stewart Cancer Trust and the staff in the Photobiology, Neurosurgical theatre, Ms Carol Goodman, Myles Padgett, Martin O’Dwyer and our patients who agreed to participate in this study.
- 5.Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV (1984) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713–719Google Scholar
- 12.Manipalam TJ, Tyrell JB, Wilson CB (1988) Transsphenoidal microsurgery for Cushing’s disease: a report of 216 cases. Ann Intern Med 109:487–493Google Scholar
- 13.Buchfelder M, Fahlbusch R, Schott W, Honegger J (1991) Long-term follow-up results in hormonally active pituitary adenomas after primary successful transsphenoidal surgery. Acta Neurochir Suppl (Wien) 53:72–76Google Scholar
- 18.Schulte HM, Allolio B, Günther RW, Benker G, Winkelmann W, Ohnhaus EE, Reinwein D (1988) Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing’s disease. Clin Endocrinol (Oxf) 28:289–295. doi: 10.1111/j.1365-2265.1988.tb01215.x CrossRefGoogle Scholar
- 19.Kaltsas GA, Giannulis MG, Newell-Price JD, Trainer PJ, Besser GM, Grossman AB (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:487–492. doi: 10.1210/jc.84.2.487 PubMedCrossRefGoogle Scholar
- 20.Booth GL, Redelmeier DA, Grosma H, Kovac K, Smyth HS, Ezzat S (1998) Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing’s disease. J Clin Endocrinol Metab 83:2291–2295. doi: 10.1210/jc.83.7.2291 PubMedCrossRefGoogle Scholar
- 22.Watson JC, Shawker H, Nieman LK, De Vroom HL, Doppman JL, Oildfield EH (1998) Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing’s disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg 89:927–932PubMedCrossRefGoogle Scholar
- 24.Lefournier V, Gatta B, Martinie M, Vasdev A, Tabarin A, Bessou P, Berge J, Bachelot I, Chabre O (1999) One transient neurological complication (sixth nerve palsy) in 166 consecutive inferior petrosal sinus samplings for the etiological diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 84:3401–3402. doi: 10.1210/jc.84.9.3401 PubMedCrossRefGoogle Scholar
- 29.Stummer W, Pitchimeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392–401. doi: 10.1016/S1470-2045(06)70665-9 PubMedCrossRefGoogle Scholar